PT - JOURNAL ARTICLE AU - Anja Jochmann AU - Daniel Trachsel AU - Jürg Hammer TI - Inflammatory bowel disease and the lung in paediatric patients AID - 10.1183/20734735.0269-2020 DP - 2021 Mar 01 TA - Breathe PG - 200269 VI - 17 IP - 1 4099 - http://breathe.ersjournals.com/content/17/1/200269.short 4100 - http://breathe.ersjournals.com/content/17/1/200269.full SO - Breathe2021 Mar 01; 17 AB - The prevalence of inflammatory bowel disease (IBD) has increased over the past 20 years. Pulmonary involvement in paediatric IBD is rare but may be missed since the spectrum of symptoms is broad and mimics other diseases. The most important differential diagnoses of pulmonary manifestations of IBD are infections and therapy-related side-effects. There is no gold standard to diagnose respiratory manifestations in children with IBD. Diagnostic tests should be chosen according to history and clinical presentation. Treatment of respiratory manifestations of IBD includes inhaled or oral corticosteroids and initiation or step-up of immunomodulatory IBD therapies.Pulmonary involvement in paediatric IBD is rare but may be underdiagnosed. The spectrum of symptoms is broad and mimics other diseases. The differentiation between IBD-related and drug-induced pulmonary manifestation can be challenging. https://bit.ly/3uZBvpA